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ABSTRACT 
Background: Nearly 95% of Americans will develop hypertension, and 67% will not seek 
treatment. Furthermore, hypertension is the leading risk factor for coronary heart disease. 
While previous studies have increased the use of blood pressure medication among 
patients that have received hypertension education, medications may not work for 
everyone.  Due to the life-threatening nature of this condition, it is essential to find an 
effective alternative for treatment. The purpose of this study was to examine the impact 
of organometallic complex supplementation on hypertension and left ventricular 
hypertrophy in 6-week old male Sprague-Dawley rats that were fed either standard rodent 
chow or a high fat diet for 10 weeks at a university in Arizona. 
Methods: Forty-two healthy six-week old male Sprague-Dawley rats were randomly 
assigned to one of three groups: plain water control, 0.6 mg/ml organometallic complex 
or 3.0 mg/ml organometallic complex as soon as they arrived. Each rat was then housed 
individually to prevent the sharing of microbiota through coprophagia. Rats in each 
treatment group were further divided into two dietary groups that were fed either a high 
fat diet containing 60% kcal fat that was changed every three days or standard rodent 
chow. Researchers were not blind to which rat was in each group. At the end of the 10-
week study, rats were euthanized with an overdose of sodium pentobarbital (200 mg/kg, 
i.p.). Heart, left ventricle of the heart, liver, and spleen masses were recorded for each 
animal. Data were analyzed by two-way ANOVA using SigmaPlot 10.0 software.   
Results: At the conclusion of this study, the left ventricle mass of the rats in the high fat 
diet group were significantly larger than those in the chow group. Neither dose of the 
organometallic complex supplement prevented these effects induced by high fat feeding.  
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Conclusion: The organometallic complex supplement was not effective at mitigating the 
effects of a high fat diet on cardiac hypertrophy in rats. Therefore, this supplement should 
not be used to treat cardiac hypertrophy.  
 
 
 
  
  iii 
ACKNOWLEDGEMENTS 
I would like to begin by thanking my Lord and Savior Jesus Christ for blessing 
me with the strenghth and wisdom that I needed to complete this thesis. I would not be 
able to do this without Him.  
Second, I would like to thank my wonderful thesis committee. Dr. Sweazea, thank 
you for your guidance and for reading through my many versions of my thesis. you are a 
great mentor and I appreciate that you were always willing to answer my questions and 
provide quick yet substantial feedback. Dr. Whisner, thank you for also reading through 
my many versions of my thesis and providing extensive feedback that has helped me to 
become a better writer. I appreciate that you agreed to be a member of my thesis 
committee. Your expertise in vitamins and minerals was very helpful. Dr. Alexon, thank 
you for also reading through my many versions of my thesis and agreeing to be on my 
thesis committee. I appreciate your feedback and expertise in nutrition, they helped me to 
write the best thesis possible. 
Last but not least, thank you to my parents who have  always loved and 
encouraged me and have listened to me talk about my thesis for the past two years.  
 
 
 
 
 
 
 
  iv 
TABLE OF CONTENTS 
       Page 
LIST OF TABLES………………………………………………………………………VI 
CHAPTER 
1  INTRODUCTION ........................................................................................................... 1  
The Study Purpose ..................................................................................... 2 
Null Hypothesis .......................................................................................... 2 
Definition of Terms .................................................................................... 2 
Delimitations .............................................................................................. 2 
  Limitations……………………………………………………………..2 
 
2  REVIEW OF LITERATURE ......................................................................................... 3  
 Rodent Model of Diet-induced Hypertension………………….………3 
 
 Hypertension…………………………………………………….....…..3 
 
 Organometallic Complex Powder Supplement…….……………….….5 
 
 Magnesium……………………………………………………………..7 
 
 Calcium and Potassium………………………………………………...8 
 
 Sulfur………………..………………………………………………….9 
 
 Conclusion…………………………………………………………….10 
   
3  METHODS…………………………………………………………………………..11 
Study Design…………………………………………………………...11 
Study Supplement……………………………………………………...13 
Statistical Analysis……………………………………………………..14 
 
  v 
CHAPTER                                                                                                                   Page 
4  RESULTS……………. ................................................................................................ 15 
Morphometrics ......................................................................................... 15 
Organ Mass .............................................................................................. 16 
5 DISCUSSION……………………………………………………………………....18 
 
REFERENCES………………………………………………………………………..22 
 
 APPENDIX 
 
                  A     FLOW CHART.....  ..................................................................................... 27 
                  B     IACUC APPROVED PROTOCOL.....  ...................................................... 29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  vi 
LIST OF TABLES 
 
TABLE          Page 
 
 
1. Properties of Organometallic Complex………………………………………….13  
 
2. Morphometrics of Sprague-Dawley Rats………………………………………16 
 
3. Organ Masses of Sprague-Dawley Rats………………………………………..17
  1 
CHAPTER 1 
INTRODUCTION 
Overview 
Nearly 95% of Americans will develop hypertension, and 67% will not seek 
treatment (Wang & Vasan 2005). Furthermore, hypertension is the leading risk factor for 
coronary heart disease (Yeo et al. 2009). While previous studies have demonstrated the 
efficacy of blood pressure medication among patients who have received hypertension 
education (Ho et al. 2016; Saleem et al. 2015), medications may not work for everyone.  
Due to the life-threatening nature of this condition, it is essential to find an effective 
alternative for treatment.  
There is a novel food grade supplement comprised of mineral powder known as an 
organometallic complex (OMC). Since it is extracted from soil, it contains minerals such 
as calcium, magnesium, sodium, potassium, sulfur, protein and fulvic acid. While the 
combination of minerals in this supplement may be beneficial for hypertension, it has not 
been tested in this capacity. Therefore, it is unclear whether there will be any effect of the 
compound on hypertensive symptoms. Furthermore, there are not enough clinical trials to 
test if nutritional supplements can elicit a decrease in hypertension and left ventricular 
hypertrophy in rats. A prior study by Deneau et al. (2011) showed that a similar 
organometallic complex effectively reversed major symptoms associated with diabetes 
including improved glucose regulation and decreased weight. However, this does not 
indicate that the organometallic complex used in the present study will prevent the heart, 
spleen and liver damage that are associated with diet-induced hypertension. 
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The Study Purpose 
The purpose of this study was to examine the impact of OMC supplementation on 
hypertension, splenomegaly and left ventricular hypertrophy in 6-week old male 
Sprague-Dawley rats that were fed either standard rodent chow or a 60% kcal high fat 
diet for 10 weeks at a university in Arizona.  
Null Hypothesis 
Ten weeks of organometallic complex supplementation in young male Sprague-Dawley 
rats will not mitigate the left ventricular hypertrophy, splenomegaly, and hypertension 
that are associated with a consumption of a high fat diet.  
Definition of Terms 
 Hypertension: High blood pressure measuring 140/90 mm Hg (Yeo et al. 2009).  
 Organometallic complex (OMC) – the novel soil-derived test compound used in the 
current study. 
Delimitations  
 Rats live in a controlled environment, so these results cannot be generalized for 
humans or animals not living in a controlled environment.  
 Hypertension was associated with a high fat diet, so these results will not apply to 
people or animals who are genetically predisposed to hypertension. 
Limitations 
 Cannot measure changes in organ weight over time within intact rats  
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CHAPTER 2 
REVIEW OF LITERATURE 
 
Rodent model of diet-induced hypertension 
Sprague-Dawley rats were used in this study due as they are commonly used in 
studies of diet-induced hypertension. For example, rats fed a high sucrose diet had the 
same significant impairment in vasodilation as rats fed a high fat diet (Sweazea et al. 
2010). An additional study not only repeated these results but also indicated that a high 
fat diet is associated with hypertension in rats (Sweazea and Walker 2012). Crinigan et al. 
(2015) also established that renal mass and visceral fat increased in rats following a six-
week high fat diet, which may indicate that chronic fat intake is needed in order to induce 
renal disease as markers of inflammation were not detected. The most recent study by 
Sweazea and colleagues used Sprague-Dawley rats to determine the effects of white 
sesame seed oil on renal function and found significant improvement in the health of their 
kidneys (Aslam et al. 2017). Given these previous results, male Sprague-Dawley rats are 
an ideal model in which to examine the efficacy of the organometallic complex at 
mitigating the deleterious effects of chronic high fat intake.   
 
Hypertension 
First, it is important to define what hypertension is. A healthy heart and arteries 
are able to expand to take the flow of blood in, which is often referred to as systolic 
pressure, and then they contract to push the blood out to the rest of the body, which is 
referred to as diastolic pressure (Franklin et al. 2008). Hypertension is diagnosed when 
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the diastolic blood pressure rises to at least 90 mm Hg or higher and the systolic blood 
pressure rises to at least 140 mm Hg or higher (Franklin et al. 2008). Because there are so 
many nonmodifiable risk factors for hypertension such as genetic predispositions 
effecting excretion of electrolytes (Firsov et al. 2012; Solocinski et al. 2015; Stow et al. 
2011), dysfunctional renal regulation of vascular tone (Rettig 1993; Rettig and Grisk 
2005), and preventing the conversion of angiotensin II to angiotensin III (Carey 2017), 
and modifiable risk factors such as consuming excessive amounts of sodium (Okamoto et 
al. 1963), fructose, or fat (Gradel et al. 2018), it is vital to discuss what researchers have 
already utilized to try to combat this issue.   
Dupas et al. (2017) randomly divided 32 three-week-old male Wistar rats into one 
of two groups: 18 rats in the fructose group, and 14 in the control group (tap water) for 
twenty-one weeks (Dupas et al. 2017). After a four-day acclimation period, rats had their 
systolic blood pressure measured through a tail cuff roughly every two weeks throughout 
the duration of the intervention (Dupas et al. 2017). Fructose drinks were refreshed every 
few days and the amount of fructose was increased once the rats were ten-weeks-old. The 
rats were weighed each week (Dupas et al. 2017).  Blood was drawn through 
venipuncture following a 15-hour-long fast and abdominal fat, muscles, hearts, and livers 
were weighed and frozen following dissection (Dupas et al. 2017). Systolic blood 
pressure and fasting blood glucose levels were significantly elevated in the fructose group 
when compared to the control group, despite not having any signs of renal failure or 
ventricular hypertrophy, but their body mass stayed the same during the course of the 
study (Dupas et al. 2017). However, rats that consumed fructose had more abdominal fat 
and greater liver mass even though the heart mass did not change (Dupas et al. 2017). 
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The rats also did not develop glucose intolerance despite the constant fructose 
consumption, amount of abdominal fat, and insulin resistance (Dupas et al. 2017). Dupas 
et al. (2017) concluded that the rapid early onset of hypertension was associated with the 
high fructose diet, but they could not determine why, especially since they did not 
measure blood pressure in the rats for the first four weeks (Dupas et al. 2017). The rats 
developed some hepatic lipid droplets, but not enough to develop fatty liver disease 
(Dupas et al. 2017). Although Dupas et al. (2017) were trying to find a link between 
fructose and metabolic syndrome, and this study induced hypertension through a high fat 
diet, the authors showed that hypertension has a strong correlation with poor diet choices.  
Another study by Hou et al. (2017) compared eight-week-old salt-sensitive rats 
that could not produce nitric oxide with rats that were not salt-sensitive (Hou et al. 2017). 
Despite the consumption of salt for seventeen consecutive days, the researchers found 
that aspartate reduced high blood pressure levels in salt sensitive rats after just one week 
(Hou et al. 2017). The supplements also raised the levels of nitric oxide in the blood and 
kidneys, which correlated with the decrease in blood pressure (Hou et al. 2017). Since 
aspartate supplements correlated with an increase in nitric oxide, and this increase 
correlated with a significant decrease in blood pressure levels (Hou et al. 2017), it would 
stand to reason that nitric oxide supplementation could lead to an even greater decrease in 
blood pressure levels.  
 
Organometallic Complex Powder Supplement 
While several studies have elucidated the benefits of supplements on 
hypertension, the only study on a similar Organometallic Complex powder supplement 
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thus far has involved diabetic mice (Deneau et al. 2011). Deneau et al. (2011) used thirty 
six week-old male mice that were genetically diabetic. The mice were randomly assigned 
to one of three groups: a tap water control group, 0.6 mg/mL, or 3 mg/mL of a 
supplement that was similar to the Organometallic Complex powder used in the present 
study. It was administered to the animals completely dissolved in water, which is similar 
to the present study, except the prior intervention lasted for only 31 days (Deneau et al. 
2011), whereas the present intervention lasted for ten weeks. Additionally, five mice 
were housed together, while this study housed rats individually, and mice were only 
weighed at the beginning and end of the intervention (Deneau et al. 2011). After the 
intervention, it was observed that the Organometallic Complex powder depressed a major 
glycation factor in diabetes, similarly to lipoic acid (Deneau et al. 2011). Additionally, 
Deneau et al. concluded that the Organometallic Complex powder was correlated with 
more efficient synthesis of adenosine tri-phosphate, upregulation of copper-zinc 
superoxide dismutase, and cellular respiration (Deneau et al. 2011). Despite consuming 
the same amount of water, the control group was significantly heavier, the 
albumin/globulin ratio was vastly lower, especially compared to the 3 mg/mL treated 
group, the alkaline phosphatase was significantly elevated and they had a massive spike 
in blood glucose levels during a non-fasted glucose tolerance test when compared to the 
intervention groups (Deneau et al. 2011). However, the hemoglobin A1C was only 
marginally higher in the control group, and the blood urea nitrogen levels were elevated, 
but only in the mice that consumed the 0.6 mg/mL dose (Deneau et al. 2011). However, it 
is unclear whether these results were from the abundance of minerals that are found in the 
Organometallic Complex powder supplement (Deneau et al. 2011). Even though these 
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researchers only looked at this supplement in regard to type 2 diabetes, their study results 
are of great relevance to the current study since they have exposed some of the ways that 
the Organometallic Complex interacts with at least one type of animal model. Although 
the results indicate that this supplement can mitigate some of the effects of type 2 
diabetes, and even correlate with weight loss, a similar complex may not relieve the 
symptoms of hypertension and enlarged left ventricles that develop with chronic high fat 
intake.  
 
Magnesium 
Because one of the main minerals in an Organometallic Complex supplement is 
magnesium, it is important to discuss the potential health benefits that are associated with 
it.  A study by Li et al. (2017) hypothesized that magnesium supplements could reduce 
hepatic encephalopathy in rats more than zinc or iron supplements (Li et al. 2017). After 
randomly assigning forty-eight male Sprague-Dawley rats into five groups of eight 
(either a magnesium group, zinc group, iron group, rifaximin group, or a hepatic 
encephalopathy control group), they found that manganese concentrations in the brain 
and blood ammonia were lower in the eight rats who consumed 50 mg/kg of magnesium 
supplements when compared to the hepatic encephalopathy group (Li et al. 2017). They 
also had higher fecal levels of manganese and magnesium (Li et al. 2017). Unfortunately, 
this study did not examine magnesium supplementation on hypertension, so the health 
benefits they found may not extend to other disorders.  
Magnesium supplements have been shown to have a preventative effect on 
hypertension. A meta-analysis looked at ten prospective cohort studies involving dietary 
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magnesium and hypertension (Han et al. 2017). While serum magnesium levels are only 
slightly associated with the risk of hypertension, consuming 100 mg of dietary 
magnesium each day significantly reduced the risk of hypertension by 5% (Han et al. 
2017).  
Unfortunately, it would appear that magnesium may be ineffective once it’s 
combined with other supplements, however. A randomized, double-blind, controlled 
crossover trial was conducted to try and reduce blood pressure for one day through K 
Citrate, KCL, or KMG Citrate supplements (Vongpatanasin et al. 2016). Out of the thirty 
participants who were in the early stages of hypertension, none of the participants who 
consumed KMG Citrate supplements (which contained 20 meq of Mg) had any change in 
blood pressure despite having decreased oxidative stress and elevated serum and urinary 
magnesium excretion levels when compared to the other supplements (Vongpatanasin et 
al. 2016). While this may have been due to the participants already controlling their 
hypertension with medication (Vongpatanasin et al. 2016), it seems unlikely that the 
magnesium in the OMC supplement will have any effect on the hypertensive rats.  
 
Calcium and Potassium  
Because this supplement contains appreciable levels of calcium and potassium, it 
is crucial to elucidate how calcium and potassium have affected hypertensive rats in prior 
studies. Tolvanen et al. (1998) have studied both of these minerals in twelve 
spontaneously hypertensive rats compared to a control group for nineteen weeks. At the 
end of the intervention period, rats who consumed both calcium and potassium 
supplements had decreased blood pressure levels significantly more than rats that were 
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given just calcium or potassium alone, but the blood pressure levels were still elevated 
compared to the non-hypertensive group (Tolvanen et al. 1998).The hearts from the 
combined supplement group also weighed less than the hypertensive rats who did not 
receive either supplement (Tolvanen et al. 1998). 
 In addition, calcium may not work in every case. A prospective cohort study by 
Wang et al. compared dietary sources of calcium with calcium supplements in over 
28,000 middle-aged women who did not have hypertension at the beginning of the study 
(Wang et al. 2008). Diet and vitamin intake were assessed through a questionnaire, and 
incidence of hypertension was reported via an annual questionnaire during the decade-
long study (Wang et al. 2008). The researchers found that women who had the lowest 
risk for hypertension consumed their calcium via low-fat dairy, whereas the calcium 
supplements had no effect (Wang et al., 2008). 
 
Sulfur 
Sulfur, another mineral in the OMC supplement, has been used to reduce 
ventricular hypertrophy in rats. A recent study administered 250 mg/kg sulfur metabolites 
from garlic paste to six male Sprague-Dawley rats for over two weeks (Khatua et al. 
2017). Their hearts and bodies weighed significantly less than rats with cardiac 
hypertrophy that did not consume sulfur from the garlic paste (Khatua et al. 2017). 
However, whether sulfur will reduce hypertrophy without garlic remains to be seen. 
Sulfur has also been tested in pulmonary hypertensive rats. Yu et al. randomly assigned 
eight male Wistar rats into an 85 mg/kg sulfur dioxide group for three weeks (Yu et al. 
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2016). By the conclusion of the study, these rats had significantly less collagen clogging 
their pulmonary artery than the eight rats in the control group (Yu et al. 2016).  
Finally, researchers Maia et al. were able to decrease blood pressure in twenty-
one-day-old male hypertensive Wistar rats with an amino acid that contains sulfur (Maia 
et al. 2014). The rats were randomly assigned to a normal diet or one that is low in 
protein, and only half of them had 2.5% of the supplement administered in their water 
bottles for three months (Maia et al. 2014). The sulfur supplement only lowered blood 
pressure levels in rats that received the protein-restricted diet (Maia et al. 2014), and 
further research is needed to understand the influence of sulfur supplementation 
combined with other types of deleterious diets.  
 
Conclusion  
 In conclusion, this literature review has shown that hypertension is so detrimental 
to one’s health that many researchers have dedicated their studies to finding various 
natural substances that can be used to attenuate this issue. While some minerals, such as 
magnesium and calcium look promising, they can yield different results in a 
supplemental form. Furthermore, while potassium chloride has been associated with an 
indirect decrease in blood pressure in rats by increasing the expelling of sodium through 
urination (Louis et al. 1971), potassium supplements may not work  depending on the  
type of hypertension (Veiras et al. 2016). 
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CHAPTER 3 
METHODS  
 
Study Design 
This study included forty-two healthy male 6-week old Sprague-Dawley rats that 
were purchased from Envigo (formerly Harlan). Arizona State University IACUC 
approval was obtained (protocol number: 17-1563R (See appendix B)) before completing 
this study. Upon arrival, rats were randomly divided into chow and high fat diet-fed 
groups. The chow diet was considered the reference diet as it was identical to the diet the 
animals were raised on (3.1 kcal/g, Envigo, Madison, WI). The 60% kcal from fat HFD 
contained 5.21 kcal/g diet (D12492; Research Diets, Inc, New Brunswick, NJ). The HFD 
was replaced every three days to prevent spoiling. Rats were fed the respective diets for 
10 weeks and had ad libitum access to food and water. Immediately upon arrival, rats in 
each of these dietary groups were further divided into three treatment groups and 
administered one of three interventions: vehicle (plain water control group), 0.6 mg/ml 
organometallic complex (OMC) or 3.0 mg/ml OMC throughout the feeding protocol. 
Sample sizes in each group were as follows, Chow + plain water (n=10), Chow + 0.6 
mg/ml OMC (n=6), Chow + 3.0 mg/ml OMC (n=6), HFD + plain water (n=8), HFD + 
0.6 mg/ml OMC (n=6), HFD + 3.0 mg/ml OMC (n=6). Each rat was housed individually 
to prevent the sharing of microbiota through coprophagia. Rats were kept in a 
temperature-controlled room with a 12:12 hour light/dark cycle.   
Blood pressure was measured every other week through tail cuff plethysmography 
with a Kent Scientific CODA Monitor (Kent Scientific, Torrington, CT). Handling of the 
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rats was kept to a minimum in order to reduce stress. At the end of the 10 week feeding 
trial, rats weighed then euthanized with an overdose (200 mg/kg, i.p.) of sodium 
pentobarbital. Body length, tail length and abdominal circumference were measured 
using flexible tension tape to the nearest cm. Epididymal fat pad, heart, left ventricle of 
the heart, liver and spleen were weighed using a Mettler Toledo analytical balance 
(model number AB204-S/FACT; Mettler Toledo, Columbus, OH).   
Study Design 
Forty-two healthy six-week old male Sprague Dawley rats were randomly assigned into 
one of three groups: plain water control group, 0.6 mg/ml organometallic complex or 3.0 
mg/ml organometallic complex as soon as they arrived. Each rat was then housed 
individually to prevent the sharing of microbiota through coprophagia. Rats in each 
treatment group were further divided into two dietary groups that were fed either a high 
fat diet containing 60% kcal fat that was changed every three days or standard rodent 
chow. Researchers were not blind to which rat was in each group. A minimum sample 
size of six rats was required for each group and determined through power analysis using 
SigmaStat 3.0 software and prior research (Sipola et al. 2001, Tanida et al.2005, Rault-
Nania et al. 2008). Blood pressure was measured through tail cuff plethysmyogaphy with 
a Kent Scientific CODA Monitor. Mass of tissues were weighed using a Mettler Toledo 
analytical balance (model number AB204-S/FACT). Weighing organs is a common 
procedure, but Kent Scientific references several published papers about measuring tail 
cuff pressures, but one study in particular by Finne et al. was able to determine that their 
rats had a particular form of hypertension by using the Kent Scientific CODA blood 
pressure monitor and cuffs (Finne et al., 2016). 
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Study Supplement  
The independent variable was a proprietary Organometallic Complex supplement 
in powder form. This supplement was a soil-derived mineraloid isolate which naturally 
occurs through the oxidation process of coal (Deneau et al. 2011). It is safe for animal 
and human consumption. The supplement in the present study was obtained through 
Isagenix International LLC from Gilbert, Arizona (Table 1). 
  
Table 1: Physical, Chemical, and Functional Characteristics of OMC 
Component Measured Concentration or Value 
 
Analytical Methodology or 
Source 
Total Minerals 142391 ppm ICP 
Calcium 49610 ppm ICP 
Sulfur 28040 ppm ICP 
Potassium 15420 ppm ICP 
Sodium 14990 ppm ICP 
Magnesium 12630 ppm ICP 
Fulvic Acids 14.9% Lamar et al., 2014 [42]  
Humic Acids <0.1% Lamar et al., 2014 [42] 
Protein 23 mg/g CLG-PRO4 determination by 
combustion 
Nucleic Acids ND DAPI (4’,6-Diamidino-2-
phenylindole)-staining 
Total Polyphenols 0.24% Folin-Ciocalteu 
ORAC Scorea-Hydrophilic 24.92 Brunswick Laboratories 
ORAC Scorea-Hydrophobic 5.44 Brunswick Laboratories 
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aORAC: oxygen radical absorbance capacity, bICP: Inductively coupled plasma mass 
spectrometry (Table from Crawford et al., In Review).  
 
Statistical Analyses 
Study results were represented as mean ± SEM. Two-way ANOVAs were 
performed to compare differences between groups. SigmaStat 3.0 software was used for 
statistical analyses, and P-values were considered significant at P<0.05. Data were tested 
for normality and log transformed when necessary.  If there was a significant 2-way 
ANOVA, Tukey post-hoc analysis was used to determine significant differences between 
dietary treatment groups.                     
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CHAPTER 4 
RESULTS 
 
Although we attempted to measure blood pressure by tail vein plethysmography, 
we were unable to obtain accurate or reproducible measurements using the KODA 
system. Therefore, these data are not presented.    
 
Morphometrics 
After the ten-week-long intervention, epididymal fat pad mass in rats in the 0.6 
mg/ml intervention group consuming a high fat diet were significantly increased: 7.44± 
1.09 g compared to 6.67 ± 0.65 g in the 3.0 mg/ml intervention group and 6.09 ± 0.32 g 
in the control group. Waist circumference in rats in the 0.6 mg/ml intervention group 
consuming a high fat diet were significantly increased: 18.9 ± 0.62 cm compared to 18.3 
± 0.24 cm in the 3.0 mg/ml intervention group and 17.9 ± 0.25 cm in the control group. 
Naso-anal length in rats in the 3.0 mg/ml intervention group consuming a high fat diet 
were also significantly increased: 23.2± 0.30 cm compared to 23.1  ± 0.20 cm in the 0.6  
mg/ml intervention group and 23.1 ± 0.14 cm in the control group. The high fat diet 
groups were also significantly increased compared to the chow groups, with the 
exception of tail length (21.3 ± 0.27 cm in the control group) and Lee’s Index of Obesity 
(327.3 ± 3.3 cm in the 0.6  mg/ml intervention group and 322.9 ± 2.5 cm 3.0 mg/ml 
intervention group). (Table 1).  
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Table 1: Morphometrics of Sprague-Dawley rats  
  Control 0.6 mg/ml 
OMC 
3.0 mg/ml 
OMC 
Epididymal fat pad mass (g)a    
Chow  3.70 ± 0.16 (10) 4.14 ± 0.24 (6) 3.89 ± 0.41 (6) 
HFD  6.09 ± 0.32 (8)# 7.44 ± 1.09 (6)# 6.67 ± 0.65 (6)# 
Waist circumference (cm)    
Chow 16.8 ± 0.28 (10) 17.5 ± 0.17 (6) 17.3 ± 0.20 (6) 
HFD  17.9 ± 0.25 (8)# 18.9 ± 0.62 (6)# 18.3 ± 0.24 (6)# 
Tail length (cm)    
Chow  21.3 ± 0.27 (10) 21.1 ± 0.29 (6) 21.4 ± 0.51 (6) 
HFD  21.3 ± 0.22 (8) 21.5 ± 0.26 (6) 21.5 ± 0.31 (6)  
Naso-anal length (cm)    
Chow 22.3 ± 0.15 (10) 22.1 ± 0.14 (6) 22.5 ± 0.24 (6) 
HFD  23.1 ± 0.14 (8)# 23.1 ± 0.20 (6)# 23.2 ± 0.30 (6)# 
Lee’s Index of Obesity    
Chow 321.1 ± 1.7 (10) 327.3 ± 3.3 (6) 322.9 ± 2.5 (6) 
HFD  321.9 ± 1.7 (8) 324.7 ± 2.8 (6) 322.0 ± 1.8 (6) 
BMI    
Chow 0.74 ± 0.01 (10) 0.77 ± 0.02 (6) 0.76 ± 0.02 (6) 
HFD  0.77 ± 0.01 (8) 0.79 ± 0.02 (6) 0.77 ± 0.01 (6) 
Data expressed as mean ± SEM (n). Data analyzed by two-way ANOVA. #p<0.02 vs 
respective chow treated animal. aData were log transformed prior to statistical analyses to 
approximate normality. Lee’s Index of Obesity = (cube root of body mass (g) / nasoanal 
length (cm)) * 1000 (Bernardis, 1970). Body mass index (BMI) = body mass (g) / 
nasoanal length (cm)2 (Novelli et al., 2007).  
 
 
Organ Mass 
Six rats in the 0.6 mg/ml intervention group consuming a high fat diet developed 
a significant increase of 1.39 ±0.05 g in heart mass compared to 1.13 ±0.04 g in the chow 
group, and 0.97 ±0.04 g in left ventricle mass compared to 0.81 ±0.02 g in the chow 
group. Rats in the 3.0 mg/ml intervention group had an increase of 1.35 ±0.03 g in heart 
mass over 1.17 ±0.04 g in the 3.0 mg/ml chow group, and an increase of 0.97 ±0.02 g in 
left ventricle mass over 0.86 ±0.03 g in the chow group. In addition, eight rats in the 
control group that consumed a high fat diet had a significant increase in left ventricle 
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mass (0.96 ±0.04 g) compared to the chow control group. (See Table 2 for all organ 
masses). However, all variations in heart and left ventricle masses were explained by diet 
alone, not the effect of either dose of the organometallic complex supplement. 
Furthermore, after normalizing to heart mass, left ventricular mass was no longer 
significantly different. All variations were explained by diet alone and there were no 
treatment effects since tail length was not significantly different between animals. 
 
Table 2: Organ masses of Sprague-Dawley rats  
  Control 0.6 mg/ml 
OMC 
3.0 mg/ml 
OMC 
Liver mass (g)a    
Chow  12.3 ± 0.42 (10) 12.1 ± 0.52 (6) 13.2 ± 0.41 (6) 
HFD  12.2 ± 0.71 (8) 12.4 ± 0.35 (6) 12.4 ± 0.36 (6) 
Spleen mass (g)    
Chow 0.75 ± 0.02 (8) 0.79 ± 0.04 (6) 0.81 ± 0.04 (4) 
HFD  0.79 ± 0.02 (6) 0.87 ± 0.06 (4) 0.77 ± 0.05 (4) 
Heart mass (g)    
Chow 1.26 ± 0.05 (10) 1.13 ± 0.04 (6) 1.17 ± 0.04 (6) 
HFD  1.33 ± 0.05 (8) 1.39 ± 0.05 (6)# 1.35 ± 0.03 (6)# 
Left ventricle mass (g)    
Chow 0.85 ± 0.03 (10) 0.81 ± 0.02 (6) 0.86 ± 0.03 (6) 
HFD  0.96 ± 0.04 (8)# 0.97 ± 0.04 (6)# 0.97 ± 0.02 (6)# 
Left ventricle/heart mass (g)a    
Chow 0.68 ± 0.02 (10) 0.71 ± 0.01 (6) 0.73 ± 0.01 (6) 
HFD  0.72 ± 0.02 (8) 0.70 ± 0.01 (6) 0.71 ± 0.01 (6) 
Data expressed as mean ± SEM (n). Data analyzed by two-way ANOVA. #p<0.02 vs 
respective chow treated animal. aData were log transformed prior to statistical analyses to 
approximate normality. 
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CHAPTER 5 
DISCUSSION 
 
As hypothesized, rats did not develop a significant difference in epididymal fat 
pad mass, waist circumference, or growth, and there were no significant differences in 
heart mass or left ventricle mass in either intervention group when compared to the 
control groups. This remained true when left ventricle mass was normalized to heart 
mass. While the present study and Deneau et al.’s intervention were similar, the slight 
differences in rodent model, duration of treatment, composition of supplements, and 
disease models may explain why an OMC supplement was beneficial for diabetes 
(Deneau et al. 2011), but did not attenuate diet-induced cardiac hypertrophy in the 
present study.  
Magnesium supplements have been associated with mediating the effects of L-
NAME-induced hypertension in rats (Ozturk et al. 2016). Ozturk et al. (2016) fed 1 gram 
per kilogram of magnesium to 20 8-week-old rats for 6 weeks. By the conclusion of the 
study, blood pressure had decreased in the magnesium-treated group to the same level as 
the control group and reduce ventricular tissue hypertrophy (Ozturk et al. 2016). While 
magnesium supplements have been shown to decrease the effects of hypertension (Ozturk 
et al. 2016), it is unknown if the dose of magnesium in the current OMC supplement was 
too low to notice an effect.  
Calcium antagonists have been shown to increase blood pressure in rats, 
indicating that calcium plays an important role in decreasing hypertension (Kang, Cregor, 
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& Smith, 1990). A study by Tolvanen et al. (1998) successfully decreased blood pressure 
in rats through a combination of potassium and calcium supplementation (Tolvanen et al. 
1998), and sulfur has been shown to decrease ventricular hypertrophy (Yu et al. 2016). 
Thus, although the OMC supplement used in the current study contains these minerals, 
they may not be in sufficient concentration to prevent cardiac hypertrophy as observed in 
the current study. Wang et al. (2008) has shown that a low-fat diet may be more 
beneficial for controlling hypertension than using supplements. In addition, the OMC 
contains fulvic acid, which may have also influenced the results of the study. One of the 
earliest studies investigated the effect of fulvic acid on ATP production on mitochondria 
in rat livers (Visser, 1987). The researchers concluded that fulvic acid can inhibit ATP 
synthesis for a short amount of time and it does not increase oxidative phosphorylation in 
mitochondria of rodent livers as much as humic acids (Visser, 1987). Fulvic acid has also 
been studied in rats due to its contribution to certain skeletal diseases (Wang et al. 1996). 
Wang and colleagues injected 40 Wistar rats with fulvic acid for 130 days and compared 
them to a control group treated with saline injections (Wang et al. 1996). The rats also 
consumed radiolabeled fulvic acid, which was found in all organs and bones following 
dissection, with the largest amounts found in the kidney and liver and the bones of the 
injected rats were brown, indicating that fulvic acid is a contributing factor of bone 
disease (Wang et al. 1996).  
Since this supplement is derived from soil, it may contain trace amounts of 
copper. Lind and Glynn (1999) researched the effects of fulvic acid on the absorption of 
copper. They divided 40 12-day-old Sprague-Dawley rat pups into groups of 10 and  
administered 0.3 ml of radiolabeled copper, copper, and fulvic acid in infant formula 
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through intubation (Lind & Glynn, 1999). After 6 hours, the pups were dissected and 
their organs were tested in a gamma counter (Lind & Glynn, 1999). Pups in the fulvic 
acid group had less retention of copper in their bodies and absorption in their intestines 
than the control group (Lind & Glynn, 1999). The researchers concluded that fulvic acid 
in drinking water may have an impact on copper absorption (Lind & Glynn, 1999). 
Therefore, it is possible that fulvic acid may have prevented the other minerals in this 
supplement from being absorbed. Another study found that while fulvic acid is associated 
with an immune response, it may also lead to hypothyroidism (Vucskits et al., 2010). 
Two experiments administering different doses of fulvic acid to rats (0.1, 0.2,0.4, and 
0.8% in one experiment and 0.4% in the other) were compared to the same doses of 
humic acid for 26 days (Vucskits et al., 2010). At the end of the first experiment, rats that 
consumed 0.4% fulvic acid had a greater increase in antibodies than the control group 
(Vucskits et al., 2010). The higher dose of fulvic acid also increased plasma thyroid 
stimulating hormone and was associated with a decrease in the T4/T3 ratio (Vucskits et 
al., 2010). While the amount of fulvic acid in the present study is unknown, it seems that 
large doses of fulvic acid may have an undesirable side effect. However, fulvic acid can 
promote wound healing and reduce inflammation in rats and mice when it is applied 
topically (Sabi et al. 2012). These results were replicated in a later study (Zhao et al., 
2015), so it is unfortunate that the same healing and anti-inflammatory properties do not 
apply to fulvic acid once it has been consumed. Furthermore, high doses of fulvic acid 
has been shown to decrease iron absorption in rats (Szabo et al., 2017), and it has been 
associated with lower levels of zinc in the large intestine and kidney (Hullar et al., 2018).  
For these reasons, further research may be warranted to determine if the dose of fulvic 
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acid in the OMC supplement is high enough to have impacted the results of the current 
study.  
In conclusion, the OMC supplement did not mitigate the effects of a high fat diet 
on cardiac hypertrophy in rats. Therefore, this supplement should not be used to treat 
cardiac hypertrophy.  
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